Superworth

Silo Pharma revenue SILO

Sales by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
$54.1K
Latest quarter, Q2 FY26
$0
−100% on a year earlier
Fiscal year 2025
$72.1K
+0% on the year before

Silo Pharma's revenue was $54.1K over the twelve months to Jun 30, 2026, down 25% on a year earlier.

In its latest quarter, Q2 FY26, it was $0, down 100% on the same quarter a year before.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$72.1K+0%
FY2024$72.1K+0%
FY2023$72.1Kn/a
FY2022n/an/a
FY2020$40.9Kn/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$0−100%$54.1K
Q1 FY26$18K+0%$72.1K
Q4 FY25$18K+0%$72.1K
Q3 FY25$18K+0%$72.1K
Q2 FY25$18K+0%$72.1K
Q1 FY25$18K+0%$72.1K
Q4 FY24$18K+0%$72.1K
Q3 FY24$18K+0%$72.1K
Q2 FY24$18K+0%$72.1K
Q1 FY24$18K+0%$72.1K
Q4 FY23$18K+0%$72.1K
Q3 FY23$18K+0%$72.1K

Against its peers

Companies in Healthcare nearest Silo Pharma's size, closest first, today.

CompanyRevenue, 12 monthsGrowth
SILOSilo Pharma$54.1K−25% a year
OXBROXBRIDGE RE HOLDINGS$2.8M+40% a year
EDUCEducational Development$20M−32% a year
GTIMGood Times Restaurants$135.1M−6% a year
MDRRMedalist Diversified$9.6M−1% a year
BCGBinah Capital$191.9M+8% a year
Peer median$20M

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Silo Pharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.